Comparative Pharmacokinetics of Dulaglutide After Administration Via an Auto-injector and a Manual Syringe in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2014
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 02 Jul 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov.
- 02 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.